NCT02463331View on ClinicalTrials.gov

Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2016

Conditions
Autoimmune Hepatitis
Interventions
DRUG

Chloroquine diphosphate

One pill of chloroquine diphosphate per day until the end of the study

DRUG

prednisone

Prednisone 5-15 mg/day until the end of the study

DRUG

azathioprine

azathioprine 1-2mg/Kg/day until the end of the study

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT02463331 - Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial | Biotech Hunter | Biotech Hunter